Although the statistical significance could not be reached due to the small cohort size, the trend showed that Ing4-deleted tumors were more metastatic, consistent with the hypothesis that ING4 deficiencies promote metastatic progression in breast cancer. Here, ING4 is linked to breast carcinoma.